The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTIGT.L Regulatory News (TIGT)

  • There is currently no data for TIGT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

4 May 2023 07:00

RNS Number : 3258Y
Troy Income & Growth Trust Plc
04 May 2023
 

To: RNS

From: Troy Income & Growth Trust plc

LEI: 213800HLNMQ1R6VBLU75

Date: 4 May 2023

 

TROY INCOME & GROWTH TRUST PLC

INTERIM RESULTS FOR THE SIX MONTHS TO 31 MARCH 2023

 

The investment objective of Troy Income & Growth Trust plc is to achieve rising income and long-term capital growth through investment in a portfolio of predominantly UK equities.

 

Financial Highlights

 

 

 

31 March 2023

30 September 2022

Change

Equity shareholders' funds

£186,264,000

£193,315,000

(3.6)%

Net asset value per share

72.05p

68.48p

5.2%

Share price (mid-market)

70.60p

67.00p

5.4%

 

Discount to net asset value

(2.0)%

(2.2)%

 

 

Total Return* (for the periods to 31 March 2023)

 

Six Months

One Year

Three Years

Five Years

 

Ten Years

 

 

 

 

 

 

Share price

7.7%

(5.0)%

9.5%

11.5%

61.1%

 

 

Net asset value per share

8.9%

(3.6)%

16.0%

15.8%

68.1%

FTSE All-Share Index

12.3%

2.9%

47.4%

27.9%

75.9%

 

* Total return includes reinvesting the net dividend in the month that the share price goes ex-dividend.

 

 

INTERIM BOARD REPORT

 

Introduction

I am pleased to have joined Troy Income and Growth Trust plc ('the Company') as a non-executive Director and Chair. On behalf of myself and the rest of the Board, I would like to thank my predecessor, David Warnock, for his committed stewardship of the Company.

 

The Company has a clear proposition. It is a UK equity investment trust that invests in high-quality, predominantly UK-listed companies, capable of providing dividend growth every year. The Company aims to offer its Shareholders progressive annual dividend growth and good total returns with lower share price volatility than the FTSE All Share Index. Uniquely in the AIC UK Equity Income sector, it also offers Shareholders the ability to purchase and sell shares in the Company whenever they want at close to net asset value due to the implementation of a strict discount control mechanism.

 

Company Aims

Since my arrival, the Board has focused on setting clearer objectives for the Company and has spent a full day's working session with the Managers to gain their input. We have agreed the Company will aim to provide the following:

 

Share price total return above the FTSE All Share Index over a 5-year period

Recent performance has fallen short of this target, with the portfolio lagging the wider market return. Calendar year 2022 in particular was a challenging period, with the rapid rise in interest rates and inflation leading to significant polarisation within equity markets. Sectors typically eschewed by the Managers for their cyclicality and capital intensity, particularly Energy and Mining, performed very strongly. Concurrently, many highly profitable and growth-oriented companies held in the portfolio suffered share price declines. The Managers see a considerably more balanced market today, with the environment well-suited to the Company's quality, dividend growth focused approach. Recent results and dividends reported by holdings provide reassurance on the strength of the portfolio and the outlook for returns in a variety of market scenarios.

 

Dividend growth of 4% per annum for Shareholders

Having paid a dividend of 0.5p for the first quarter of the financial year, the Company paid 0.51p in the second quarter. This represents growth of c.4% on last year's second quarter dividend. It is the Board's intention going forward to target annual dividend growth of 4%, market conditions permitting.

 

Over recent years, the Company's portfolio has evolved. The Managers have prioritised companies able to deliver progressive dividend growth and sold out of companies with higher yields that lack the potential for long term dividend growth. It is encouraging for the Board to see income growth from the portfolio feeding through to revenues. Given the Managers' confidence in the robustness of the portfolio's dividends, and the Company's strong revenue reserves, the Board has decided to increase the rate of dividend growth for the Company.

 

Share price volatility lower than the FTSE All Share Index

The Managers emphasise high-quality, resilient, dividend-paying businesses that should drive consistent returns, avoiding the worst of market volatility. In particular, they believe a portfolio suffering fewer and less destructive drawdowns will be in a better position to compound returns over the long run. The Company has consistently fared better than the FTSE All-Share Index during market sell-offs and has continued to provide a return with lower share price volatility. The discount control mechanism has played an important role in this, ensuring the Company's share price remains closely aligned with net asset value.

 

The Board will closely monitor the Company's progress against these aims and will report on this in the annual report and accounts.

 

Performance

The Company delivered a Net Asset Value ('NAV') per share total return of +8.9% and a share price total return of +7.7% over the six months to 31 March 2023. Over the same period, the FTSE All Share Index produced a total return of +12.3%. The average NAV total return for the AIC UK Equity Income sector was +12.6% for the same period. Looking back over time, it has not been unusual for the Company to lag the index and peers in periods of particularly strong markets. The two most significant drags were the Company's holdings in large, low cyclicality Consumer Staples companies, and sterling's strong appreciation against the dollar impacting the Company's US-listed holdings.

 

There was strong performance from a range of large, stable holdings within the portfolio over the six-month period. RELX, Unilever, National Grid, Compass and AstraZeneca contributed most strongly to returns. Other areas of strength came from UK domestically focused businesses such as Next and Domino's Pizza, as these stocks recovered from the dislocation caused by the UK's September 2022 mini-budget. Another notable theme across markets over the period related to China's re-opening following over two years of strict COVID lockdowns. This was most obviously manifested within the portfolio by the sharp rise in the share price of InterContinental Hotels Group, a company with a strong exposure to Chinese travel. Across the broader index, commodity producers, which the Company does not hold, were also beneficiaries of this trend.

 

Background

The market continued to digest the impact of high inflation and higher interest rates over the six-month period. UK inflation (CPI growth) hit 11.1% in October 2022, the highest level since the 1970's. Whilst it is likely that this reading represented peak inflation for this current cycle, the path for inflation returning to the Bank of England's ('BOE') 2% target is highly uncertain. In response to such readings, the BOE continued to hike interest rates. On the 23 March 2023, the UK base rate was raised for the eleventh consecutive time to 4.25%, having been as low as 0.1% in December 2021.

 

The magnitude and speed of interest rate rises in response to inflation is having acute and unpredictable impacts on the market. In September 2022, we witnessed a crisis in UK pensions. More recently, in March 2023, significant stress emerged in the US regional banking system. This resulted in Silicon Valley Bank's collapse, in what was the first major US bank run since the global financial crisis. Other banks across the world, including Credit Suisse, suffered varying degrees of contagion and whilst there has been limited direct read across so far to the UK banks, these events provided a reminder as to the risks associated with highly levered business models.

 

The Managers have chosen not to invest in banks, due to the leverage and cyclicality inherent in their business models. Instead, they seek to invest in resilient, high-quality dividend growth companies that have relatively lower levels of share price volatility.

 

Portfolio

Large, high-quality, low cyclicality businesses continue to make up the core of the portfolio. Some of the Company's largest allocations include a c.30% weighting to Consumer Staples (e.g. Unilever, Diageo and Reckitt), c.20% to non-discretionary B2B-focused businesses (e.g. Compass Group, RELX and Bunzl) and c.10% to the relatively non-cyclical Healthcare sector (e.g. AstraZeneca and GSK).

 

Over the period, the Managers took advantage of market volatility to make new investments in London Stock Exchange Group, Sage, Smiths Group, Imperial Brands and Howden Joinery. All five are resilient, leading companies in their respective industries and have strong balance sheets and well-covered, growing dividends.

 

The Managers exited positions in Haleon, Halma and Aveva Group. Aveva was subject to a bid by its majority shareholder Schneider Electric, following which the position was sold. Haleon and Halma were sold on valuation and dividend yield grounds.

 

While the team follow a long-term, low turnover strategy, they will continue to seek to improve the growth of capital values and dividends within the portfolio.

 

Discount Control Mechanism

The discount control mechanism ('DCM') is one way in which the Company sets itself apart from other trusts in the sector. The DCM materially improves the liquidity of the Company's shares and ensures Shareholders can purchase and sell shares in the Company at a price that closely reflects the NAV. This is particularly important during times of market stress, where it is not uncommon for other trusts to trade at a material discount to their NAV's.

 

The Company has operated the DCM since Troy became the Company's Manager in 2009 and it continues to be a key aspect of the Company's proposition.

 

Dividends

The Board announced in March that the Company would pay a second interim dividend of 0.51p per share (2022 - 0.49p). This represents a step up in the rate of the Company's dividend growth to c.4% compared the prior year's second interim. Absent any unforeseen circumstances, it is the Board's objective to maintain this rate of dividend growth going forward.

 

This increase in the dividend signals the Managers' confidence in the underlying portfolio and the Board's strong desire to deliver dividend growth to Shareholders. The Company's dividend growth can be expected to be sustainable through a wide variety of market environments, with the current annual dividend covered by almost 11 months of revenue reserves.

 

Recent corporate results continue to demonstrate strong dividend growth from some significant portfolio holdings. Highlights included +10% growth in the final dividends from RELX and InterContinental Hotels Group, +8% from Croda and LSE Group, and +11% from Bunzl.

 

Outlook

The Managers believe that the lagged impact of higher interest rates and high inflation will continue to affect companies, consumers, and certain parts of the financial system. March brought significant volatility to markets, with pockets of stress emerging in the US and European banking systems. Regulators have acted fast to avoid contagion, but after more than a decade of low rates, the Managers are braced for further speed bumps, as well as possible recessions in Europe and the US.

 

The Board is confident that the companies held in the portfolio are resilient and adaptable. Over recent months, the Managers have digested encouraging results from a range of the Company's businesses. Strong operations are feeding through to strong dividend growth from several core holdings; 10% growth in RELX's latest dividend, 9% from Reckitt, 8% from Croda, and 10% from Bunzl - the latter marking 30 years of unbroken growth at a 10% compound annual rate. These are reassuring signals by management teams on the outlook for their businesses. All of these businesses have proven to be reliable, long-term income payers over many years, and are typical of the companies preferred by the Managers. The Board believes that the consistent, compounding dividend returns possible from such businesses support a robust outlook for total returns from your Company.

 

Bridget Guerin

Chairman

3 May 2023

 

Principal Risks and Uncertainties

The principal risks facing the Company relate to the Company's investment activities and include performance risk, market risk, resource risk and operational risk. Other risks faced by the Company include breach of regulatory rules which could lead to suspension of the Company's Stock Exchange Listing, financial penalties, or a qualified audit report. Breach of Section 1159 of the Corporation Tax Act 2010 could lead to the Company being subject to tax on capital gains.

 

An explanation of these principal risks and how they are managed is contained in the Strategic Report within the Annual Report and Accounts for the year ended 30 September 2022.

 

The Company's principal risks and uncertainties have not changed materially since the date of the Annual Report and no material changes are foreseen over the remainder of the year.

 

Going Concern

The Directors have undertaken a rigorous review of the Company's ability to continue as a going concern. This review included consideration of the Company's investment objective, its principal risks, the nature and liquidity of the portfolio, current liabilities and expenditure forecasts.

 

The Company's investments consist mainly of readily realisable securities which can be sold to maintain adequate cash balances to meet expected cash flows. In assessing the Company's ability to meet its liabilities as they fall due, the Directors took into account the economic and market outlook. They also considered ongoing investor interest in the continuation of the Company, looking specifically at feedback from meetings and conversations with Shareholders by the Company's advisers, and the operation of the DCM, which the Directors believe enhances the Company's appeal to investors.

 

Based on their assessment and considerations, the Directors believe it is appropriate to continue to adopt the going concern basis in preparing the financial statements.

 

Directors' Responsibility Statement

The Directors are responsible for preparing the half yearly financial report in accordance with applicable law and regulations. The Directors confirm that to the best of their knowledge:

- the condensed set of interim financial statements contained within the half yearly financial report have been prepared in accordance with International Accounting Standard 34; and

- the Interim Board Report includes a fair review of the information required by 4.2.7R (indication of important events during the first six months of the financial year and description of principal risks and uncertainties for the remaining six months of the year) and 4.2.8R (disclosure of related party transactions and changes therein) of the FCA's Disclosure Guidance and Transparency Rules.

The half yearly financial report for the six months to 31 March 2023 comprises the Interim Board Report, the Directors' Responsibility Statement and a condensed set of financial statements.

 

For and on behalf of the Board

 

Bridget Guerin

Chairman

3 May 2023

STATEMENT OF COMPREHENSIVE INCOME

 

Six months ended

31 March 2023

(unaudited)

Six months ended

31 March 2022

(unaudited)

Revenue

Capital

Total

Revenue

Capital

Total

Notes

£'000

£'000

£'000

£'000

£'000

£'000

Capital

Gains on investments held at fair value

-

12,337

12,337

-

882

882

Net foreign currency gains

-

18

18

-

21

21

Revenue

Income from listed investments

2

2,500

-

2,500

2,601

-

2,601

Other income

7

-

7

-

-

-

_______

______

_______

_______

______

_______

2,507

12,355

14,862

2,601

903

3,504

 

_______

______

_______

_______

______

_______

Expenses

Investment management

(187)

(347)

(534)

(258)

(479)

(737)

fees

Other administrative

(324)

-

(324)

(351)

-

(351)

expenses

Finance costs of borrowing

(50)

(93)

(143)

-

-

-

_______

______

_______

_______

______

_______

Profit before taxation

 

1,946

11,915

13,861

1,992

424

2,416

Taxation

3

(74)

-

(74)

(58)

-

(58)

_______

______

_______

_______

______

_______

Total comprehensive income

1,872

11,915

13,787

1,934

424

2,358

_______

______

_______

_______

______

_______

Earnings per Ordinary

5

0.68

4.35

5.03

0.61

0.14

0.75

share (pence)

_______

______

_______

_______

______

_______

 

The total column of this statement represents the Statement of Comprehensive Income prepared in accordance with UK-adopted international accounting standards.

 The revenue return and capital return columns are supplementary to this and are prepared under guidance published by the Association of Investment Companies.

No operations were acquired or discontinued during the period.

 

STATEMENT OF COMPREHENSIVE INCOME

(CONTINUED)

Year ended

30 September 2022

(audited)

 

Revenue

Capital

Total

Notes

£'000

£'000

£'000

Capital

Losses on investments held at fair value

-

(25,889)

(25,889)

Net foreign currency gains

-

52

52

Revenue

Income from listed investments

2

6,666

-

6,666

Other income

-

-

-

______

______

______

6,666

(25,837)

(19,171)

______

______

______

Expenses

Investment management fees

(465)

(864)

(1,329)

Other administrative expenses

(686)

-

(686)

Finance costs of borrowing

(19)

(35)

(54)

______

_______

______

Profit before taxation

5,496

(26,736)

(21,240)

Taxation

3

(109)

-

(109)

______

_______

______

Total comprehensive income/(expense)

5,387

(26,736)

(21,349)

 

______

_______

______

Earnings per Ordinary share (pence)

5

1.77

(8.80)

(7.03)

 

 

______

_______

______

 

STATEMENT OF FINANCIAL POSITION

 

 

As at

31 March

2023

(unaudited)

£'000

 As at

31 March

2022

(unaudited)

£'000

As at

30 September

2022

(audited)

£'000

 

 

 

 

 

Notes

Non-current assets

Investments in ordinary shares

6

189,428

229,141

194,448

______

______

______

Investments held at fair value through profit or loss

189,428

229,141

194,448

______

______

______

Current assets

Accrued income and prepayments

850

878

890

Trade and other receivables

551

36

3,665

Cash and cash equivalents

3,027

5,388

4,710

______

______

______

Total current assets

4,428

6,302

9,265

______

______

______

Total assets

193,856

235,443

203,713

Current liabilities

Bank loan

(5,000)

-

(5,000)

Trade and other payables

(2,592)

(940)

(5,398)

______

______

______

Total current liabilities

(7,592)

(940)

(10,398)

______

______

______

Net assets

 

186,264

234,503

193,315

 

______

______

______

Issued capital and reserves attributable to

equity holders

Called-up share capital

7

86,878

86,878

86,878

Share premium account

53,817

53,882

53,851

Special reserves

-

25,542

9,684

Capital reserve - unrealised

25,317

51,377

18,854

Capital reserve - realised

15,595

11,899

17,152

Revenue reserve

4,657

4,925

6,896

______

______

______

Equity shareholders' funds

 

186,264

243,503

193,315

______

______

______

Net asset value per Ordinary share (pence)

5

72.05

77.53

68.48

 

______

______

______

 

 

STATEMENT OF CHANGES IN EQUITY

 

 

 

 

 

 

 

 

Six months ended 31 March 2023 (unaudited)

 

Share

 

Capital

Capital

 

 

 

Share

premium

Special

reserve -

reserve -

Revenue

 

 

capital

account

reserves

unrealised

realised

reserve

Total

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

 

Balance at 1 October 2022

86,878

53,851

9,684

18,854

17,152

6,896

193,315

 

Profit and total comprehensive income for the period

-

-

-

6,463

5,452

1,872

13,787

 

Equity dividends

-

-

-

-

-

(4,111)

(4,111)

 

Shares bought back into treasury

-

-

(16,693)

-

-

-

(16,693)

 

Discount control costs

-

(34)

 -

 -

 -

 -

(34)

 

Transfer from capital reserves

-

-

7,009

-

(7,009)

-

-

 

 

______

_______

______

______

______

_______

______

 

Balance at 31 March 2023

86,878

53,817

-

25,317

15,595

4,657

186,264

 

______

_______

______

______

______

_______

______

 

 

Six months ended 31 March 2022 (unaudited)

 

Share

 

Capital

Capital

 

 

 

Share

premium

Special

reserve -

reserve -

Revenue

 

 

capital

account

reserves

unrealised

realised

reserve

Total

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

 

Balance at 1 October 2021

86,878

53,909

38,890

54,428

8,424

6,092

248,621

 

(Loss)/profit and total comprehensive income for the period

-

-

-

(3,051)

3,475

1,934

2,358

 

Equity dividends

-

-

-

-

-

(3,101)

(3,101)

 

Shares bought back into treasury

-

-

(13,348)

-

-

-

(13,348)

 

Discount control costs

-

(27)

 -

 -

 -

 -

(27)

 

______

_______

______

______

______

_______

______

 

Balance at 31 March 2022

86,878

53,882

24,542

51,377

11,899

4,925

234,503

 

 

______

_______

______

______

______

_______

______

 

 

 

Year ended 30 September 2022 (audited)

 

Share

 

Capital

Capital

 

 

 

Share

premium

Special

reserve -

reserve -

Revenue

 

 

capital

account

reserves

unrealised

realised

reserve

Total

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

 

Balance at 1 October 2021

86,878

53,909

38,890

54,428

8,424

6,092

248,621

 

(Loss)/profit and total comprehensive income for the year

 

-

 

-

 

-

 

(35,574)

 

8,838

 

5,387

 

(21,349)

 

Equity dividends

-

-

(1,444)

-

-

(4,583)

(6,027)

 

Shares bought back into treasury

-

-

(27,872)

-

-

-

(27,872)

 

Discount control costs

-

(58)

-

-

-

-

(58)

 

Transfer from capital reserves

-

-

110

-

(110)

-

-

 

 

______

______

______

______

______

______

______

 

Balance at 30 September 2022

86,878

53,851

9,684

18,854

17,152

6,896

193,315

 

 

______

_______

______

______

______

_______

______

 

 

The revenue reserve, special reserves and capital reserve - realised are distributable. The full amount of each of these reserves is available for distribution.

 

 

CASH FLOW STATEMENT

 

 

 

Six months

ended

31 March

2023

(unaudited)

£'000

Six months

ended

31 March

2022

(unaudited)

£'000

Year

ended

30 September

2022

(audited)

£'000

Cash flows from operating activities

 

 

 

Investment income received

2,570

2,700

6,876

Administrative expenses paid

(872)

(1,182)

(2,140)

______

______

______

Cash generated from operations

1,698

1,518

4,736

Finance costs paid

(116)

-

(60)

Taxation

(106)

(58)

(179)

______

______

______

Net cash inflows from operating activities

1,476

1,460

4,497

______

______

______

Cash flows from investing activities

 

 

 

Purchases of investments

(23,280)

(14,677)

(51,123)

Sales of investments

42,290

30,960

73,668

Capital distributions received from investee companies

-

-

113

______

______

______

Net cash inflow from investing activities

19,010

16,283

22,658

______

______

______

Net cash inflow before financing

20,486

17,743

27,155

 

______

______

______

Financing activities

Proceeds from loan

-

-

5,000

Cost of share buybacks

(19,365)

(13,199)

(25,365)

Dividends paid

(2,791)

(3,101)

(6,027)

Discount control costs

(31)

(27)

(56)

______

______

______

Net cash outflows from financing activities

(22,187)

(16,327)

(26,448)

______

______

______

Net (decrease)/increase in cash and cash equivalents

(1,701)

1,416

707

Cash and cash equivalents at the start of the period

4,710

3,951

3,951

Effect of foreign exchange rate changes

18

21

52

______

______

______

Cash and cash equivalents at the end of the period

3,027

5,388

4,710

 

______

______

______

Reconciliation of operating profit to operating cash flows

Profit/(loss) before taxation

13,861

2,416

(21,240)

Add interest payable

143

-

54

Adjustments for:

(Gains)/losses on investments

(12,337)

(882)

25,889

Currency gains

(18)

(21)

(52)

Decrease in accrued income and prepayments

62

89

200

Decrease in trade and other payables

(13)

(84)

(115)

 

______

______

______

Cash generated from operations

1,698

1,518

4,736

 

______

______

______

 

Distribution of Assets and Liabilities

 

 

 

Valuation at

30 September

2022

 

 

 

Valuation at

31 March

2023

 

 

 

 

 

Purchases

Sales

Appreciation/

(depreciation)

£'000

%

£'000

£'000

£'000

£'000

%

Listed investments

 

 

 

 

 

 

 

Ordinary shares

194,448

100.6

21,819

(39,176)

12,337

189,428

101.7

Current assets

9,265

4.8

4,428

2.4

Current liabilities

(10,398)

(5.4)

(7,592)

(4.1)

______

_____

______

_____

Net assets

193,315

100.0

 

 

 

186,264

100.0

 

______

_____

______

_____

Net asset value per share

68.48p

 

 

 

 

72.05p

 

 

______

______

 

NOTES TO THE ACCOUNTS

 

 

1.

Accounting policies

(a)

Basis of accounting

The financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS) IAS 34 - 'Interim Financial Reporting', as adopted by the International Accounting Standards Board (IASB), and interpretations issued by the International Financial Reporting Interpretations Committee of the IASB (IFRIC). They have also been prepared using the same accounting policies applied for the year ended 30 September 2022 financial statements

(b)

Dividends payable

Dividends are recognised on the ex-dividend date.

 

2.

Income

Six months ended

31 March

2023

£'000

Six months ended

31 March

2022

£'000

Year

 ended

30 September

2022

£'000

 

Income from listed investments

 

 

 

UK dividend income

1,950

2,221

5,783

Overseas dividend income

550

380

883

______

______

______

2,500

2,601

6,666

 

 

______

______

______

 

Other income from investment activity

 

 

 

Deposit interest

7

-

-

______

______

______

 

Total income

2,507

2,601

6,666

 

 

______

______

______

 

3.

Taxation

The taxation charge for the period represents withholding tax suffered on overseas dividend income.

 

4.

Revenue and Dividends

The following table shows the revenue for each period less the dividends declared and payable from revenue in respect of the financial period to which they relate.

 

 

Six months ended

31 March

2023*

£'000

Six months ended

31 March

2022+

£'000

Year

 ended

 30 September

2022++

£'000

Revenue

1,872

1,934

5,387

Dividends declared and payable from revenue

(2,700)

(3,017)

(4,430)

______

______

______

(828)

(1,083)

957

______

______

______

* Dividends declared relate to the first two interim dividends (of 0.50p and 0.51p) declared in respect of the financial year 2022/2023.

 

+ Dividends declared relate to the first two interim dividends (both 0.49p) declared in respect of the financial year 2021/2022.

 

++ Dividends declared relate to the first, second and fourth interim dividends declared in respect of the financial year 2021/2022 totalling 1.48p and paid from revenue. The third interim dividend of 0.49p was paid from the distributable capital reserve.

 

 

Six months ended

31 March 2023

Six months ended

31 March 2022

Year

 ended

30 September

 2022

 

 

5.

Return and net asset value per share

p

p

p

 

Revenue return

0.68

0.61

1.77

 

Capital return

4.35

0.14

(8.80)

 

______

______

______

 

Total return

5.03

0.75

(7.03)

 

______

______

______

 

The figures above are based on the following:

 

£'000

£'000

£'000

 

Revenue return

1,872

1,934

5,387

 

Capital return

11,915

424

(26,736)

 

______

______

______

 

Total return

13,787

2,358

(21,349)

 

______

______

______

 

 

 

 

 

 

 

Weighted average number of Ordinary shares in issue

273,794,251

313,192,468

303,874,343

 

__________

__________

__________

 

 

 

 

 

 

 

 

The net asset value per share is based on net assets attributable to shareholders of £186,264,000 (31 March 2022 - £234,503,000; 30 September 2022 - £193,315,000) and on 258,507,487 (31 March 2022 - 302,462,487; 30 September 2022 - 282,284,487) Ordinary shares in issue at the period end.

 

6.

Financial instruments

 

 

 

 

 

 

Level 1

£'000

Level 2

£'000

Level 3

£'000

 

2023

Total

£'000

Financial assets at fair value through profit or

loss as at 31 March 2023

 

 

 

 

Investments

189,428

-

-

189,428

 

 

______

______

______

______

 

In accordance with International Financial Reporting Standards, investments are classified using the fair value hierarchy:

Level 1 reflects financial instruments quoted in an active market.

Level 2 reflects financial instruments the fair value of which is evidenced by comparison with other observable current market transactions in the same instrument or based on a valuation technique whose variables include only data from observable markets.

Level 3 reflects financial instruments the fair value of which is determined in whole or in part using a valuation technique based on assumptions that are not supported by prices from observable market transactions in the same instrument and not based on available observable market data.

There were no transfers of investments between levels during the six months ended 31 March 2023.

The fair value of the Company's financial assets and liabilities as at 31 March 2023 was not materially different from the carrying value.

 

As at

31 March 2023

(unaudited)

As at

31 March 2022

(unaudited)

As at

30 September 2022

(audited)

7.

Ordinary share capital

 

 

 

 

 

Ordinary shares of 25p each

No. of shares

No. of shares

No. of shares

Allotted, called-up and fully paid

258,507,487

302,462,487

282,284,487

Held in treasury

89,004,500

45,049,500

65,227,500

____________

____________

___________

347,511,987

347,511,987

347,511,987

____________

____________

____________

During the six months to 31 March 2023, the six months to 31 March 2022 and the year to 30 September 2022, the Company did not issue any new shares and no shares were re-issued from treasury.

During the six months to 31 March 2023 23,777,000 shares were repurchased by the Company at a total cost of £16,693,000 and placed in treasury. During the six months to 31 March 2022 17,426,500 shares were repurchased by the Company at a total cost of £13,348,000 and placed in treasury. During the year to 30 September 2022 37,604,500 shares were repurchased by the Company at a total cost of £27,872,000 and placed in treasury.

During the six months to 31 March 2023, the six months to 31 March 2022 and the year to 30 September 2022, no Ordinary shares were purchased for cancellation.

 

8.

Transaction costs

 

During the period expenses were incurred in acquiring or disposing of investments classified as held at fair value through profit or loss. These have been expensed through capital and are included within profits on investments in the Statement of Comprehensive Income. The total costs were as follows:

 

Six months ended

31 March 2023

£'000

Six months ended

31 March 2022

£'000

Year

 ended

30 September 2022

£'000

 

 

 

Purchases

92

70

243

 

Sales

14

11

29

 

______

______

______

 

106

81

272

 

______

______

______

 

 

 

9.

Publication of non-statutory accounts

The financial information contained in this Half Yearly Financial Report does not constitute statutory accounts as defined in Sections 434-436 of the Companies Act 2006. The financial information for the six months ended 31 March 2023 and 31 March 2022 has not been audited.

 

The information for the year ended 30 September 2022 has been extracted from the latest published audited financial statements which have been filed with the Registrar of Companies. The report of the auditors on those accounts contained no qualification or statement under Section 498 (2), (3) or (4) of the Companies Act 2006.

 

 

10.

Approval

 

This Half Yearly Financial Report was approved by the Board on 3 May 2023.

 

 

11.

This Half Yearly Financial Report will shortly be available for viewing on the Company's website (www.tigt.co.uk) and will be posted to shareholders in May 2023.

 

For Troy Income & Growth Trust plc

Juniper Partners Limited, Company Secretary

3 May 2023

Enquiries: 0131 378 0500

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR QXLFBXELBBBB
Date   Source Headline
25th Mar 20242:47 pmRNSReclassification of Shares
22nd Mar 20245:03 pmRNSNet Asset Value(s)
22nd Mar 202411:35 amRNSNet Asset Value(s)
21st Mar 202412:33 pmRNSNet Asset Value(s)
20th Mar 202412:39 pmRNSNet Asset Value(s)
19th Mar 202412:10 pmRNSNet Asset Value(s)
18th Mar 20241:20 pmRNSNet Asset Value(s)
15th Mar 20244:44 pmRNSResult of Elections
15th Mar 202411:46 amRNSNet Asset Value(s)
14th Mar 202412:05 pmRNSNet Asset Value(s)
13th Mar 20244:46 pmRNSResult of General Meeting
13th Mar 202412:28 pmRNSNet Asset Value(s)
12th Mar 20241:04 pmRNSNet Asset Value(s)
11th Mar 202412:19 pmRNSNet Asset Value(s)
8th Mar 20243:54 pmRNSHolding(s) in Company
8th Mar 202412:38 pmRNSNet Asset Value(s)
7th Mar 202412:11 pmRNSNet Asset Value(s)
6th Mar 202411:15 amRNSNet Asset Value(s)
5th Mar 202412:33 pmRNSNet Asset Value(s)
5th Mar 202410:39 amRNSAnnual General Meeting
4th Mar 202411:31 amRNSNet Asset Value(s)
1st Mar 202412:11 pmRNSNet Asset Value(s)
29th Feb 202411:25 amRNSNet Asset Value(s)
28th Feb 202410:40 amRNSNet Asset Value(s)
27th Feb 202412:45 pmRNSNet Asset Value(s)
26th Feb 202411:57 amRNSNet Asset Value(s)
23rd Feb 20243:39 pmRNSPublication of a Prospectus and Circular
23rd Feb 20243:36 pmRNSPublication of Circular
23rd Feb 202412:09 pmRNSNet Asset Value(s)
22nd Feb 202412:07 pmRNSDividend Declaration
22nd Feb 202411:58 amRNSNet Asset Value(s)
21st Feb 202411:21 amRNSNet Asset Value(s)
20th Feb 202410:48 amRNSHolding(s) in Company
20th Feb 202410:25 amRNSNet Asset Value(s)
19th Feb 202410:59 amRNSNet Asset Value(s)
16th Feb 202412:27 pmRNSNet Asset Value(s)
15th Feb 202411:40 amRNSNet Asset Value(s)
14th Feb 202411:30 amRNSNet Asset Value(s)
13th Feb 202411:44 amRNSNet Asset Value(s)
9th Feb 202411:53 amRNSNet Asset Value(s)
8th Feb 202411:14 amRNSNet Asset Value(s)
7th Feb 202411:25 amRNSNet Asset Value(s)
6th Feb 202412:48 pmRNSNet Asset Value(s)
5th Feb 20241:17 pmRNSNet Asset Value(s)
2nd Feb 20241:00 pmRNSNet Asset Value(s)
1st Feb 202411:18 amRNSNet Asset Value(s)
31st Jan 202410:42 amRNSNet Asset Value(s)
30th Jan 202411:30 amRNSNet Asset Value(s)
29th Jan 202411:40 amRNSNet Asset Value(s)
26th Jan 20242:38 pmRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.